Skip to main content
News

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

GLP-1s must now include warning for potential increased risk of vision loss, FDA announces

Feed excerpt — reported by CBS News

The FDA announced that GLP-1 weight loss drugs will now include warning labels indicating a potential increased risk of vision loss.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at CBS News →

Original Source

This article was syndicated from CBS News. All rights remain with the original publisher.